ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
Source: SeekingAlpha
2026-02-04 13:32:33 ET
More on related tickers
- Trane Technologies: Upgrade To Buy On Cheaper Valuation And Better Fundamentals
- Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript
- Linde Q4 2025 Earnings Preview
- Genentech in up to $1.7B RNAi licensing deal with SanegeneBio
Read the full article on Seeking Alpha
For further details see:
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
EssilorLuxottica
NASDAQ: ESLOF
ESLOF Trading
-0.77% G/L:
$239.25 Last:
181 Volume:
$239 Open:
ESLOF Latest News
ESLOF Stock Data
$133,939,122,404
445,231,933
N/A
1153
N/A
Medical Equipment & Supplies
Healthcare
FR
Paris
